{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T09:28:57Z","timestamp":1793611737370,"version":"4.5.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Prophylactic vasopressor infusions have been recommended for preventing spinal-induced hypotension during caesarean delivery in normotensive patients, but they should be used with caution in patients with preeclampsia due to concerns about exacerbating their haemodynamic instability. Ondansetron has been reported to effectively reduce the incidence of hypotension and decrease the need for vasopressors without causing significant adverse effects in both obstetric and nonobstetric patients undergoing spinal anaesthesia. Nevertheless, evidence regarding its use specifically in patients with preeclampsia remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>This study aimed to evaluate the efficacy of ondansetron in preventing spinal anaesthesia-induced hypotension in preeclamptic patients undergoing caesarean delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DESIGN<\/jats:title>\n                    <jats:p>A prospective, double-blinded, randomised clinical trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SETTING<\/jats:title>\n                    <jats:p>Single university hospital.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PARTICIPANTS<\/jats:title>\n                    <jats:p>One hundred and twenty preeclamptic patients were enrolled and allocated to Group O and Group C.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>INTERVENTIONS<\/jats:title>\n                    <jats:p>\n                      Patients in Group O receive intravenous ondansetron (4\u200amg\u200a2\u200aml\n                      <jats:sup>\u22121<\/jats:sup>\n                      ) or in Group C receive 0.9% saline placebo (2\u200aml) 10\u200amin before spinal injection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MAIN OUTCOME MEARSURES<\/jats:title>\n                    <jats:p>The primary outcome of the study was the incidence of hypotension. Secondary outcomes included consumption of phenylephrine, the incidence of side effects, and neonatal outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      The incidence of spinal anaesthesia-induced hypotension was higher in Group C than in Group O (55 vs. 30%, mean difference: 25%, 95% CI, 8.4 to 43.9%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0009). The relative risk of hypotension associated with or without intravenous ondansetron administration was 0.55 (95% CI, 0.34 to 0.84).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>The intravenous administration of 4\u200amg of ondansetron can effectively reduce the incidence of spinal anaesthesia-induced hypotension, and consequently decrease the requirement for phenylephrine in patients with preeclampsia undergoing caesarean delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TRIAL REGISTRATION<\/jats:title>\n                    <jats:p>ChiCTR2400080284<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/eja.0000000000002402","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:04:30Z","timestamp":1777536270000},"page":"994-1000","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The effect of intravenous ondansetron on maternal spinal-induced hypotension in preeclamptic patients undergoing caesarean delivery"],"prefix":"10.1097","volume":"43","author":[{"given":"Fei","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Sai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Ping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Zhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"R1-20261102","doi-asserted-by":"crossref","first-page":"l2381","DOI":"10.1136\/bmj.l2381","article-title":"Preeclampsia: pathophysiology and clinical implications","volume":"366","author":"Burton","year":"2019","journal-title":"BMJ"},{"key":"R2-20261102","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1001\/jama.2017.3439","article-title":"Screening for preeclampsia: US Preventive Services Task Force recommendation statement","volume":"317","author":"Davidson","year":"2017","journal-title":"JAMA"},{"key":"R3-20261102","first-page":"1122","article-title":"Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on hypertension in pregnancy","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R4-20261102","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1213\/01.ANE.0000175229.98493.2B","article-title":"Spinal anesthesia-induced hypotension: a risk comparison between patients with severe preeclampsia and healthy women undergoing preterm caesarean delivery","volume":"101","author":"Aya","year":"2005","journal-title":"Anesth Analg"},{"key":"R5-20261102","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1213\/01.ANE.0000073610.23885.F2","article-title":"Patients with severe preeclampsia experience less hypotension during spinal anesthesia for elective cesarean delivery than healthy parturients: a prospective cohort comparison","volume":"97","author":"Aya","year":"2003","journal-title":"Anesth Analg"},{"key":"R6-20261102","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/bja\/76.5.616","article-title":"Maternal and uteroplacental haemodynamic state in preeclamptic patients during spinal anesthesia for cesarean section","volume":"76","author":"Karinen","year":"1996","journal-title":"Br J Anasth"},{"key":"R7-20261102","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1213\/ANE.0b013e31829eeef5","article-title":"Focused review: spinal anesthesia in severe preeclampsia","volume":"117","author":"Henke","year":"2013","journal-title":"Anesth Analg"},{"key":"R8-20261102","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/anae.14080","article-title":"International consensus statement on the management of hypotension with vasopressors during caesarean section under spinal anaesthesia","volume":"73","author":"Kinsella","year":"2018","journal-title":"Anaesthesia"},{"key":"R9-20261102","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/ALN.0000000000005296","article-title":"Perioperative management of patients with preeclampsia: a comprehensive review","volume":"142","author":"Dennis","year":"2025","journal-title":"Anesthesiology"},{"key":"R10-20261102","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijoa.2015.08.012","article-title":"Effects of prophylactic ondansetron on spinal anesthesia-induced hypotension: a meta-analysis","volume":"24","author":"Gao","year":"2015","journal-title":"Int J Obstet Anesth"},{"key":"R11-20261102","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1213\/ANE.0000000000001511","article-title":"Prevention of spinal anesthesia-induced hypotension during cesarean delivery by 5-Hydroxytryptamine-3 receptor antagonists: a systematic review and meta-analysis and meta-regression","volume":"123","author":"Heesen","year":"2016","journal-title":"Anesth Analg"},{"key":"R12-20261102","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1213\/ANE.0000000000004534","article-title":"A prospective, randomized, double-blinded study of the effect of intravenous ondansetron on the effective dose in 50% of subjects of prophylactic phenylephrine infusions for preventing spinal anesthesia-induced hypotension during cesarean delivery","volume":"131","author":"Xiao","year":"2020","journal-title":"Anesth Analg"},{"key":"R13-20261102","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/ACO.0000000000000835","article-title":"Preeclampsia and the anaesthesiologist: current management","volume":"33","author":"Russell","year":"2020","journal-title":"Curr Opin Anaesthesiol"},{"key":"R14-20261102","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/01.AOG.0000151116.84113.56","article-title":"Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure","volume":"105","author":"Martin","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R15-20261102","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/anae.14268","article-title":"Randomised double-blind comparison of bolus phenylephrine or ephedrine for treatment of hypotension in women with preeclampsia undergoing caesarean section","volume":"73","author":"Mohta","year":"2018","journal-title":"Anaesthesia"},{"key":"R16-20261102","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijgo.2016.06.012","article-title":"Randomized controlled trial comparing ondansetron and placebo for the reduction of spinal anesthesia-induced hypotension during elective cesarean delivery in Egypt","volume":"135","author":"El Khouly","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"key":"R17-20261102","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ijoa.2011.08.002","article-title":"Reduction in spinal-induced hypotension with ondansetron in parturients undergoing caesarean section: a double-blind randomised, placebo-controlled study","volume":"21","author":"Sahoo","year":"2012","journal-title":"Int J Obstet Anesth"},{"key":"R18-20261102","first-page":"5210","article-title":"Efficacy of prophylactic intravenous ondansetron on the prevention of hypotension during cesarean delivery: a dose-dependent study","volume":"7","author":"Wang","year":"2014","journal-title":"Int J Clin Exp Med"},{"key":"R19-20261102","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/AAP.0000000000000274","article-title":"Ondansetron does not attenuate hemodynamic changes in patients undergoing elective cesarean delivery using subarachnoid anesthesia: a double-blind, placebo-controlled, randomized trial","volume":"40","author":"Terkawi","year":"2015","journal-title":"Reg Anesth Pain Med"},{"key":"R20-20261102","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijoa.2014.01.005","article-title":"The effect of intravenous ondansetron on maternal haemodynamics during elective caesarean delivery under spinal anaesthesia: a double-blind, randomised, placebo-controlled trial","volume":"23","author":"Ortiz-G\u00f3mez","year":"2014","journal-title":"Int J Obstet Anesth"},{"key":"R21-20261102","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12871-018-0568-7","article-title":"Minimal effective weightbased dosing of ondansetron to reduce hypotension in cesarean section under spinal anesthesia: a randomized controlled superiority trial","volume":"18","author":"Oofuvong","year":"2018","journal-title":"BMC Anesthesiol"}],"container-title":["European Journal of Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/EJA.0000000000002402","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T09:00:17Z","timestamp":1793610017000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/EJA.0000000000002402"}},"subtitle":["A randomised, controlled clinical trial"],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/eja.0000000000002402","relation":{},"ISSN":["0265-0215","1365-2346"],"issn-type":[{"value":"0265-0215","type":"print"},{"value":"1365-2346","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"2025-11-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}